ER beta inhibits proliferation and invasion of breast cancer cells
about
Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonistsA positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cellsLigand-independent activation of estrogen receptor alpha by XBP-1DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor statusHow does the estrogen receptor work?Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cellsEstrogen receptors in gastric cancer: Advances and perspectivesAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerThe Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the RiskPutative biomarkers and targets of estrogen receptor negative human breast cancerThe p53-estrogen receptor loop in cancerCyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivoPotential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancerStructure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cellsThe role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ17β-estradiol represses myogenic differentiation by increasing ubiquitin-specific peptidase 19 through estrogen receptor αThe effect of antineoplastic drugs in a male spontaneous mammary tumor modelDefects of prostate development and reproductive system in the estrogen receptor-alpha null male miceERbeta in breast cancer--onlooker, passive player, or active protector?The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific.Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin.Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.Δ(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ)Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cellsEstrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.The unliganded long isoform of estrogen receptor beta stimulates brain ryanodine receptor single channel activity alongside with cytosolic Ca2+.Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulationSomatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breastEstrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling.GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerEstrogen receptor α/β-cofactor motif interactions; interplay of tyrosine 537/488 phosphorylation and LXXLL motifs.Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genisteinEstrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancerEstrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
P2860
Q21091197-0BC20250-DB9D-4247-860D-ABD9130DDD19Q24302285-819EB7E3-971C-42C1-B563-093036166B3FQ24678871-C9BADA7D-695D-4443-83CC-946953C30F57Q24794574-AEA5CDD0-98F7-4C20-9D33-78BE5080E5A6Q24802294-851D302D-030B-4EF5-9678-33596F2C4969Q24803840-EF9175C2-6864-45F6-8326-E26553692D1FQ26764916-E915B1D8-DCAC-4C4C-A221-615B520565CBQ26773907-0992ECD3-FD24-4803-935A-95FA688F8A79Q26821782-DE2536D5-08A2-4A69-AB34-5D97D1A7E5FEQ27003285-0A3927B5-C51B-4F23-9915-503186AD1BB0Q27027865-2DED8F9E-7EE4-4B22-A125-7E58870D826FQ27302901-FFAC5C3E-93F3-439B-B3B5-0B97C3137F81Q27319512-CFDB264B-B1AE-48F0-AD73-23C06BF4B07BQ28343990-9883ACE6-C377-4EC8-99B3-84188EB93203Q28390036-FD15BA70-7DB0-437A-AE97-DC59E83E02FAQ28480546-60974EA4-84C2-4B0A-8690-C9F5FB651A61Q28512427-7DE1237D-1548-4830-ADB6-8BDE67D8F915Q28533591-DF026FB7-2977-41B7-98B1-6579171CFF08Q28585567-E39B3AA3-B404-4874-A977-B01D0E469681Q30438399-93157D96-E7DB-4BD3-8F5D-492BCDBB4FADQ30540362-8C2C2244-7AE9-4A41-ACEE-3AFE9E26F8CCQ30841338-8259F894-B393-4570-AD18-846228F69591Q33503908-F32014AE-0F07-47B3-97CC-27D4B74ABCA6Q33601161-B66F6352-DB8B-4707-95D6-F59A82FDF24BQ33636941-BDD08328-BB47-4313-9C61-454EB0A6D51AQ33638946-32FFAA71-33B7-40BF-92FB-F3EFE6FCCF90Q33642747-0FE870DF-A4D8-44FD-94C1-BFE7F2A79882Q33651509-C3D20613-A63E-4B7D-89F6-59FFD1D1545CQ33718203-12B0F1EF-BD49-4104-9014-52F21457EBE9Q33750241-AA51A9B8-701A-42EC-9DB0-D80B45733B99Q33793540-2F9E2BC5-8E5A-4F24-82B1-E3CA2BE77D44Q33864656-7700BCC4-0080-419C-80FE-5823F1F3E4E5Q33882180-074EC81A-3C2E-4653-9E0C-2650788D88ABQ34125558-CE14F278-FF3A-4F42-B04A-325B190C70E1Q34230244-D4056C0E-C0FF-4D00-8345-F4BFAD71A132Q34334131-D314EBA9-416A-441B-A009-0955CE01482FQ34396913-33F46ABC-02DB-49B5-9B45-D02FE6991A01Q34454890-E5AB39C3-D2BC-45B3-A434-E098D49BA18EQ34991926-FE8E4B27-44D0-4C02-9866-119A33DB3A40Q35558946-9831A2AE-6960-475E-B434-CF8ED6638072
P2860
ER beta inhibits proliferation and invasion of breast cancer cells
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
ER beta inhibits proliferation and invasion of breast cancer cells
@ast
ER beta inhibits proliferation and invasion of breast cancer cells
@en
type
label
ER beta inhibits proliferation and invasion of breast cancer cells
@ast
ER beta inhibits proliferation and invasion of breast cancer cells
@en
prefLabel
ER beta inhibits proliferation and invasion of breast cancer cells
@ast
ER beta inhibits proliferation and invasion of breast cancer cells
@en
P2093
P2860
P1433
P1476
ER beta inhibits proliferation and invasion of breast cancer cells
@en
P2093
P2860
P304
P356
10.1210/EN.142.9.4120
10.1210/ENDO.142.9.8395
P407
P577
2001-09-01T00:00:00Z